Current Weather

Right Now
70°
Sunny
  • Humidity: 30%
  • Cloud Coverage:%
  • Wind: 6 mph
  • UV Index: 0 Low
  • Sunrise: 06:37:19 AM
  • Sunset: 06:50:43 PM

Today

Clear skies. Low 43F. Winds ESE at 5 to 10 mph.

Tonight

Clear skies. Low 43F. Winds ESE at 5 to 10 mph.

Tomorrow

Sunny. High 76F. Winds SSE at 5 to 10 mph.

Recent Obituaries

Local & Social Scene

Follow us on Facebook


CRAWFORDSVILLE — F.C. Tucker West Central is pleased to announced its August listing and sales leader. With an outstanding month, agent Lindsey Salts is the August listing and sales leader, according to information provided.

Recently I had the honor and pleasure of being invited to attend the Sept. 13 Hoosier State Press Association Summit to address the preservation of publication of public notices in newspapers.

I am an interested possible beneficiary of the Jordan Creek Wind Project (JCWP). I live out of state and nowhere near Jordan Creek. I have very little, if any, control of whether the property involving me will lend their land to the project. However, I have spent my youth working on the farm…

  • Updated

INDIANAPOLIS, Sept. 20, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Verzenio(®) (abemaciclib) in combination with standard adjuvant endocrine therapy (ET) significantly decreased the risk of breast cancer recurrence by 25 percent compared to standard adjuvant ET alone for people with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) high risk early breast cancer (HR: 0.747; 95% CI: 0.598, 0.932; p = 0.0096). This statistically significant benefit was consistent across all pre-specified subgroups and corresponds to a 3.5 percent difference between arms (92.2 percent in the Verzenio arm and 88.7 percent in the control arm) at two years. These results are from a preplanned interim analysis with 323 IDFS events observed in the intent-to-treat population across both arms, including 136 in the Verzenio arm and 187 in the control arm. The data were presented today in the Presidential Symposium at the European Society for Medical Oncology (ESMO) 2020 Virtual Congress and simultaneously published in the Journal of Clinical Oncology.